Lancet Oncol 18 (11): 1502-1511, 2017.[PUBMED Abstract] Del Mastro L, Mansutti M, Bisagni G, et al.: Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol 22 (10): 1458-1467, 2021.[PUBMED Abstract] Gnant M, Fitzal F, Rinnerthaler G, et al.: Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med 385 (5): 395-405, 2021.[PUBMED Abstract] Iwase T, Saji S, Iijima K, et al.: Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.